择期全髋关节置换术遵循外科护理改进项目指南后的发病率与死亡率
该研究基于美国全国住院患者样本库2003至2011年345,875例择期全髋关节置换术数据,评估外科护理改进项目(SCIP)指南实施前后心脏并发症与死亡率的变化。结果显示SCIP实施后心脏并发症相关总体死亡率下降41%,非致命性低血压所致非致命性心脏事件发生率增加5%,而术后住院死亡率、卒中、致命性低血压、致命性心肌梗死及非致命性和致命性心脏骤停均显著下降。
要点
- SCIP指南实施后,全髋关节置换术后心脏并发症相关总体死亡率下降41%。
- 非致命性心脏事件发生率增加5%,主要继发于非致命性低血压发生率增加。
- 术后住院死亡率、卒中、致命性低血压、致命性心肌梗死及非致命性和致命性心脏骤停均显著下降。
核心结论
- SCIP指南实施后,心脏并发症相关总体死亡率下降41%,致命性心脏并发症、术后低血压、心肌梗死和心脏骤停均显著下降。
- 尽管SCIP指南已于2015年废止,证据支持在初次择期成人全髋和膝关节置换术中继续围手术期β受体阻滞。
研究设计与样本
- 研究查询美国全国住院患者样本库(Nationwide Inpatient Sample),纳入2003至2011年实施的345,875例择期全髋关节置换术。
- 研究比较SCIP指南实施前后患者人口学特征、发病率以及非致命性和致命性心脏并发症发生率和心脏并发症相关总体死亡率。
主要发现
- SCIP指南实施后,心脏并发症相关总体死亡率下降41%。
- SCIP指南实施后,全髋关节置换术后非致命性心脏事件发生率增加5%,主要继发于非致命性低血压发生率增加。
- SCIP指南实施后,术后住院死亡率、卒中、致命性低血压、致命性心肌梗死以及非致命性和致命性心脏骤停均显著下降。
关键数值与推荐
- SCIP指南实施后心脏并发症相关总体死亡率下降41%。
- SCIP指南实施后非致命性心脏事件发生率增加5%,主要继发于非致命性低血压发生率增加。
临床怎么用
- 作者认为,尽管SCIP指南已于2015年废止,证据支持在初次择期成人全髋和膝关节置换术中继续围手术期β受体阻滞。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Following evidence questioning the safety and efficacy of perioperative beta-blocker therapy in noncardiac surgery, the Surgical Care Improvement Project (SCIP) guidelines were retired in 2015. However, perioperative myocardial infarctions and cardiac complications remain leading causes of mortality following noncardiac surgery. The impact of the SCIP guidelines on reducing cardiac complications in patients undergoing elective total hip arthroplasty (THA) has not been evaluated. METHODS: The Nationwide Inpatient Sample was queried for 345,875 elective THA performed from 2003 to 2011. Patient demographics and morbidity as well as the incidence of nonfatal and fatal cardiac complications and overall mortality associated with cardiac complications were determined before and following SCIP implementation. RESULTS: Following the institution of the SCIP guidelines, the overall mortality following cardiac complications decreased by 41%. Although the incidence of nonfatal cardiac events after THA did increase 5% (primarily secondary to an increased incidence of nonfatal hypotension), the incidence of postoperative inpatient mortality, stroke, fatal hypotension, fatal myocardial infarction, and nonfatal and fatal cardiac arrest significantly decreased. CONCLUSION: Following the implementation of SCIP guidelines, there was a 41% reduction in mortality and a significant decrease in fatal cardiac complications, postoperative hypotension, myocardial infarction, and cardiac arrest. Despite SCIP guidelines being retired in 2015, evidence supports continuation of perioperative beta-blockade in primary elective total adult hip and knee arthroplasty.
引用
- Bemenderfer TB, Rozario NL, Moore CG, et al. Morbidity and Mortality in Elective Total Hip Arthroplasty Following Surgical Care Improvement Project Guidelines. J Arthroplasty. 2017. PMID: 28366317. doi:10.1016/j.arth.2017.02.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。